Sau Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 M
as on 11-12-2024
- Revenue 17.45%
(FY 2023)
- Profit 23.38%
(FY 2023)
- Ebitda 23.51%
(FY 2023)
- Net Worth 39.79%
(FY 2023)
- Total Assets 66.29%
(FY 2023)
About Sau Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.00 M.
Sanjay Singh, Vijay Singh, and Gopichandra Maurya serve as directors at the Company.
- CIN/LLPIN
U51397MH2011PTC214682
- Company No.
214682
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Sau Pharma Private Limited offer?
Sau Pharma Private Limited offers a wide range of products and services, including Sexual Wellness Products, Contraceptives, Diagnostic Medical Imaging Equipment, Doppler Machine, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Diabetes Medicine, Common Disease Medicines, Pharmaceutical Medicine, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Sau Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Singh  | Additional Director | 12-Mar-2011 | Current |
| Vijay Singh | Director | 02-Dec-2014 | Current |
| Gopichandra Maurya | Additional Director | 17-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Sau Pharma.
Sau Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.45% increase. The company also saw a substantial improvement in profitability, with a 23.38% increase in profit. The company's net worth Soared by an impressive increase of 39.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sau Pharma?
Unlock access to Sau Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 05 Mar 2020 | ₹8.00 M | Open |
How Many Employees Work at Sau Pharma?
Unlock and access historical data on people associated with Sau Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sau Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sau Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
